Anti-Psoriatic Effects of Antimony Compounds In Vitro
Psoriasis is a chronic inflammatory skin disease characterized by hyperproliferation of keratinocytes and a pro-inflammatory milieu in the skin. While patients with moderate to severe psoriasis are treated using targeted therapies (small molecules and monoclonal antibodies), patients suffering from...
Main Authors: | Fabian Gendrisch, Birgit Haarhaus, Christoph M. Schempp, Ute Wölfle |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/19/5814 |
Similar Items
-
The Effect of Herbal Medicinal Products on Psoriasis-Like Keratinocytes
by: Fabian Gendrisch, et al.
Published: (2021-03-01) -
New Herbal Biomedicines for the Topical Treatment of Dermatological Disorders
by: Julia Hoffmann, et al.
Published: (2020-02-01) -
Involved and Uninvolved Psoriatic Keratinocytes Display a Resistance to Apoptosis that may Contribute to Epidermal Thickness
by: Cecilia Bivik Eding, et al.
Published: (2017-05-01) -
Current Concepts of Psoriasis Immunopathogenesis
by: Marijana Vičić, et al.
Published: (2021-10-01) -
Toxic response of antimony in the Comamonas testosteroni and its application in soil antimony bioremediation
by: Xiong Luo, et al.
Published: (2023-08-01)